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To the Editor: Transfusion-trans-
mitted malaria, although extremely
uncommon in most countries not
endemic for malaria, may have fatal
consequences if undetected (1,2).
Benito and Rubio (3) addressed this
timely issue by presenting data on
screening of blood donors at risk for
malaria in Spain with a seminested
polymerase chain reaction (SNM-
PCR). Of 125 donors at risk (immi-
grants from malarious areas), these
researchers identified five cases of
Plasmodium falciparum by using
SNM-PCR with a 5-mL EDTA blood
sample. Benito and Rubio’s conclu-
sion was that the SNM-PCR could
serve as the reference test for screen-
ing blood (3). Obviously, this conclu-
sion implies the potential use of blood
donations from donors who were at
risk but whose PCR results were nega-
tive. We believe that this practice
would be dangerous and could lead to
the administration of unsafe blood.
The PCR, like any method based on
direct detection of the parasite, does
have a shortcoming: the amount of
specimen processed determines the
limit of detection. Even if the described
PCR method detected a single parasite
in the 5-mL blood sample used by the
authors (3) (hypothetical sensitivity
0.0002 parasites/µL), a standard 450-
mL blood donation could still contain
<90 parasites and have a negative PCR
result. However, with the “best” sensi-
tivity reported by Benito and Rubio (3)
of 0.004 parasites/µL, a standard 450-
mL blood donation could contain
<1,800 parasites and still be tested neg-
ative by SNM-PCR. Surely, <1,800 par-
asites is enough to cause disease in a
blood recipient. As few as 10 parasites
per donation (perhaps even fewer) may
cause disease. Theoretically, any
method would have to detect a single
parasite per unit of blood to be safe,
thus requiring a hypothetical detection
limit of 2.2x10-6 parasites/µL. How-
ever, a sample equal to the unit of
donated blood (450 mL) would have to
be processed to achieve this level. In
addition, one would have to assume that
parasites are equally distributed in the
peripheral blood at the time of donation.
Little is known about the fre-
quency of very low parasitemias. No
large-scale epidemiologic studies have
been conducted in which large
amounts of blood (e.g., the equivalent
of a blood donation or 450 mL) were
collected. The authors (3) could not
confirm the PCR-positive cases by
microscopy. This finding suggests
very low levels of parasitemia, below
the sensitivity of thick smears, in the
range of 1–20 parasites per µL (4).
Similar results were observed in blood
donors associated with transfusion-
transmitted malaria in the United
States, in which malaria smears were
positive in only 17 of 49 donors (1).
PCR is similar to microscopy in
screening donors at risk, even if the
detection limits are different. Hommel
and Gilles report in Topley and Wilson
that for disease-endemic countries
“the use of PCR… …is not, despite its
much increased sensitivity, a complete
guarantee of safe blood, because the
absence of parasites in a 20-µL sample
does not exclude the possibility of
infection in the remaining volume of
the 450 mL blood unit” (5).
On the other hand, one might
argue that screening the whole blood
supply for malaria by PCR may detect
the rare blood donation with undetec-
ted malaria, with higher parasitemias.
However, the generally accepted
deferral criteria for blood donors at
risk seem highly efficient. In the
United States, only 14 cases of trans-
fusion-transmitted malaria were
reported from 1990 through 1999 (1).
The same authors estimate that this
deferral policy led to 50,000 rejected
donations in a total of 13 million per
year (0.3%). At an estimated expense
of $2.00–$3.00 per PCR, a general
screening program would cost more
than $20 million–$30 million per year.
Each case of malaria prevented would
therefore cost in excess of several mil-
lion U.S. dollars.
Several novel diagnostic methods
have been developed recently (6).
However, we agree with Mungai et al.
(1). These methods, including PCR,
have still not been shown to detect the
lowest possible parasitemia that can
cause malaria. Showing that a method
is able to detect donors at risk for
malaria, as done by Benito and Rubio
(3), is insufficient. On the contrary, the
only convincing study design would
be to show that donors at risk who
have a negative PCR result also do not
harbor parasites and cannot transmit
the disease. Accordingly, careful
screening of blood donors in nondis-
ease-endemic countries, in accordance
with the established exclusion criteria,
remains the best way to prevent trans-
mission of malaria (1,2).
T. Hänscheid,* E. Valadas,* 
and M.P. Grobusch†
*Faculty of Medicine, Hospital de Santa
Maria, Lisboa, Portugal; and †Institute of
Tropical Medicine, Tuebingen, Germany
References
  1. Mungai M, Tegtmeier G, Chamberland M,
Parise M. Transfusion-transmitted malaria
in the United States from 1963 through
1999. N Engl J Med 2001;344:1973–8.
    2. Slinger R, Giulivi A, Bodie-Collins M,
Hindieh F, St. John R, Goldman M, et al.
Transfusion-transmitted malaria in Canada.
CMAJ 2001;164:377–9.
  3. Benito A, Rubio JM. Usefulness of semin-
ested polymerase chain reaction for screen-
ing blood donors at risk for malaria in
Spain. Emerg Infect Dis 2001;7:1068.
  4. Dowling MAC, Shute GT. A comparative
study of thick and thin blood films in the
diagnosis of scanty malaria parasitaemia.
Bull World Health Organ 1966;34:249–67.
  5. Hommel M, Gilles HM. Malaria. In: Col-
lier L, Balows A, Sussman M, editors. Top-
ley and Wilson’s microbiology and
microbial infections. Vol. 4, Parasitology.
London: Arnold; 1998. p. 384–409.
  6. Hänscheid T. Diagnosis of malaria: review
of alternatives to conventional microscopy.
Clin Lab Haematol 1999;21:235–45.